trial news

AGITG Trial News

Trial news: The AGITG currently has eleven studies open to recruitment and four studies in follow up.

The  table below details the trials that are currently accruing patients.

Recruited Target
ACTICCA-1- Gallbladder carcinoma 3 50
ASCOLT — Colorectal cancer 299 400
CONTROL NETs — NeuroEndocrine Tumour 70 75
DYNAMIC-III 48 1000
DYNAMIC-Rectal 2 408
INTEGRATE II – Gastro-Oesophageal 33 90
LIBERATE 17 100
MONARCC 1 80
NABNEC 22 70
SPAR 2  222
TOP GEAR – Stomach cancer 199 280

Trial Results Lay Summaries (click on the links below):Recruitment figures to end July 2018.


ALaCaRT

ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST

Share